Bayesian Inference
A statistical framework that updates prior beliefs with observed data to produce posterior probabilities — contrasted with frequentist statistics, and increasingly used in AI model training, adaptive trials, and uncertainty quantification.
What it means
Bayesian inference is a method of statistical reasoning that uses Bayes’ theorem to update the probability of a hypothesis as new evidence accumulates:
Posterior ∝ Likelihood × Prior
In plain terms: you start with a prior belief about how likely something is, observe data that carries evidence about it (the likelihood), and combine them to get a posterior — your updated belief after seeing the data.
Contrasted with frequentist statistics: Frequentist methods (t-tests, p-values, confidence intervals) treat probability as the long-run frequency of an event and do not incorporate prior beliefs. Bayesian methods treat probability as a degree of belief that can be updated. The practical difference:
- A frequentist 95% confidence interval means “95% of intervals computed this way will contain the true parameter” — a statement about the procedure
- A Bayesian 95% credible interval means “there is a 95% probability the parameter falls in this range, given the data and prior” — a statement about the parameter itself
Relevance to AI and machine learning
Bayesian neural networks attach probability distributions to weights rather than point estimates, enabling uncertainty quantification — a model that knows what it doesn’t know. This is especially valuable in scientific applications where overconfident predictions are dangerous (medical diagnosis, drug property prediction).
Bayesian optimization is the algorithm behind tools like Bayesian Adaptive Experimentation — it builds a probabilistic model of how inputs map to outputs and uses it to choose the next experiment that gives the most information. This is why it outperforms random or grid search for expensive experiments.
RLHF and fine-tuning have Bayesian interpretations: the pre-trained model encodes a prior over likely text; fine-tuning on task-specific data updates toward a posterior.
Why it matters for researchers
Adaptive clinical trials use Bayesian updating to modify enrollment or treatment allocation mid-trial based on accumulating evidence, reducing the number of patients exposed to inferior treatments. The FDA has released guidance accepting Bayesian adaptive designs for medical device and drug trials.
Prior choice matters. A Bayesian analysis is only as good as the prior. Uninformative priors (intentionally diffuse, letting data dominate) are common in scientific settings to avoid injecting subjective beliefs. Informative priors from previous studies can improve estimates when data is limited but must be documented and justified.
Bayesian meta-analysis allows incorporating prior studies as a prior distribution over the effect size, producing more calibrated estimates than frequentist pooling when the number of primary studies is small.